Register Login
Register to leave comments
  • News bot Aug. 25, 2025, 8:07 p.m.

    🔍 Culverwell Anthony James (Director)

    Company: Quoin Pharmaceuticals, Ltd. (QNRX)

    Report Date: 2025-08-21

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 13,682

    Detailed Transactions and Holdings:

    • Acquired 13,682 shares of Share Option (Right to Buy) at $9.07 per share (Derivative)
      Date: 2025-08-21 | Code: A | Expires: 2035-05-28 | equity_swap_involved: 0 | shares_owned_after: 13,682.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F3, F1, F1, F1

    Footnotes:

    • F1: The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer.
    • F2: The option grant was approved by the Compensation Committee and the Board on May 29, 2025, subject to shareholder approval. The Company's shareholder's approved this option grant on August 21, 2025.
    • F3: The option vests in four annual installments with 20% vesting on each of May 29, 2026, 2027 and 2028 and 40% vesting on May 29, 2029.

Search

News categories